 |
First
Announcement
28
Years
1983
- Hamburger Symposia on Tumor Markers - 2011
Tumor
Associated Substances in Tumor Diagnosis and Tumor Therapy
|
 |
|

|
|
|
International
Workshop
May
29-31, 2011
|
|
|
| Research, Actual State and
Trends in Tumor Diagnosis and Therapy |
|
Location
|
Hotel
Grand Elysee - Hamburg
Rothenbaumchaussee 10
20148 Hamburg
Telefon
|
+49 40
414 12-0
|
Fax
|
+49 40
414 12-733
|
eMail
|
elysee-hamburg@t-online.de
|
Internet
|
www.elysee-hamburg.de
|
|
Chairman
|
Prof. Dr. R. Klapdor
Hamburger
Symposien über Tumormarker
Bergstraße
14, 20095 Hamburg
Telefon
|
+49 40
309 55-19
|
Fax
|
+49 40
309 55-28
|
Rothenbaumchaussee 5, 20148 Hamburg
Telefon
|
+49 40
410 2558
|
Fax
|
+49 40
410 2568
|
eMail
|
Prof.Klapdor@t-online.de
|
Internet
|
www.hstm.de
|
|
Organization
|
Hamburger Symposien über Tumormarker
and ZeTDT GmbH (Centre for
clinical and experimental Tumormarker Diagnosis and Therapy) in
cooperation with the UCCH
(University Cancer Center Hamburg, Hubertus Wald Tumorzentrum),
supported by the EGTM
(European Group on Tumor Markers).
|
Official Languages
|
English / German
Simultaneous translation
|
Scientific Advisory
Board
|
Prof. Dr. D. Arnold,
Hamburg, Germany
Prof. Dr. V. Barak, Jerusalem, Israel
Prof. Dr. C. Bokemeyer, Hamburg, Germany
Dr. J.M.G. Bonfrer, Amsterdam, The Netherlands
Dr. J. Delinassios, Athens, Greece
Prof. Dr. M. Dietel, Berlin, Germany
Dr. A. A. Epenetos, London, UK
Dr. C. Fenner, Hamburg, Germany
Dr. C. Haglund, Helsinki, Finland
Prof. Dr. I. R. Izbicki, Hamburg, Germany
Prof. Dr. R. Klapdor, Hamburg, Germany
Prof. Dr. R. Lamerz, Munich, Germany
Dr. P. Molina, Barcelona, Spain
Prof. Dr. W. Müller-Ruchholtz, Kiel, Germany
Dr. M. Nap, Heerlen, The Netherlands
Prof. K. Pantel, Hamburg, Germany
Prof. Dr. G. Sauter, Hamburg, Germany
Dr. P. Stieber, Munich, Germany
Dr. C. Sturgeon, Edinburgh, UK
Prof. Dr. O. Topolcan, Pilsen, Czech Republic
Dr. G.C. Torre, Albenga, Italy
Prof. Dr. A. Semjonow, Münster, Germany
|
Main Topics
|
Tumor related
substances (Tumor markers, oncogenes, receptors)
- in vitro diagnosis
- in vivo diagnosis
- immunhistology / immuncytology
- Tumordiagnosis
- Tumortherapy
State and trends in immunotherapy
Gentherapy – state and potential possibilities
Molecular screening and role for tumor therapy
Net work structures regarding care and clinical research
New targeted treatment strategies
Metabolic tumor control
Pretherapeutical sensitivity tests
Self-help-organizations: Acitivites and potential role in
clinical oncology and care of tumor patients
Satellite Symposium:
Tumor diseases of the pancreas - actual state and trends in diagnosis
and therapy.
|
Publication
|
The Abstracts will
be published in a supplement of "Anticancer Research" and will be
available at the Congress.
The full manuscripts
of the presentation will be published as
Proceedings of the Congress in a further supplement of "Anticancer
Research" in the year 2011 or in early 2012. To assure early
publication, the full manuscripts have to be submitted for publication
at the Congress (Microsoft Word format preferred), before their
presentation.
|
Industrial
Exhibition
|
An exhibition of the
leading industries in tumor diagnosis and tumor therapy is being
arranged during the Congress. It will be open from May 29-31, during
the meeting hours of the Congress. For further information please
contact the Congress Organization.
|
Poster
Awards
|
A
committee of the "Scientific Advisory Board" will again select each day
of the scientific programm two poster presentations for Poster Awards
combined with a cheque of 500 Euro and 250 Euro respectively. The
Awards will be distributed at the end of the daily scientific programms.
|
Submission
of abstracts
|
By mail until March
20, 2011,
by
email until March 30, 2011 - latest until April 10, 2011
|
Registration
fee
|
160,00 Euro active
participants (inclusive Abstract Book and proceedings)
|
MTA
and Students
|
50,00 Euro (incl.
Abstract Book)
|
Bank
account
|
ZeTDT GmbH, HASPA
1238 160335, BLZ 20050550
Use:
Separate account: 15th HSTM, Prof. Klapdor
IBAN:
DE42 20050550 1238 160 335
BIC/SWIFT:
HASPDEHHXXX
|
The symposium is
kindly supported by leading companies on the field of tumor diagnosis
and therapy.
Location plan:
|
|